α-Conotoxin PIA (TFA)-5 mg

Description

α-Conotoxin PIA TFA is a nicotinic acetylcholine receptor (nAChR) antagonist that targets nAChR subtypes containing α6 and α3 subunits. α-Conotoxin PIA has the potential for the research of Parkinson’s disease, and schizophrenia[1]。–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–Neuroscience-Neurodegeneration–C85H128F9N27O31S4—-[1]Seung-Wook Chi , et al. Solution Structure of Alpha-Conotoxin PIA, a Novel Antagonist of alpha6 Subunit Containing Nicotinic Acetylcholine Receptors. Biochem Biophys Res Commun. 2005 Dec 30;338(4):1990-7.—-2323.33–99.05–O=C(N[C@@H](CC(O)=O)C(N1[C@@H](CCC1)C(N[C@@H](CSSC[C@@H](C(N[C@@H]([C@H](O)C)C(N[C@@H](C(C)C)C(N[C@@H](CC2=CNC=N2)C(N[C@@H](CC(N)=O)C(N3[C@@H](CCC3)C(N[C@@H](CCC(N)=O)C(N[C@H]4[C@@H](C)CC)=O)=O)=O)=O)=O)=O)=O)NC5=O)C(N[C@@H](CSSC[C@@H](C(N)=O)NC4=O)C(N[C@@H](CO)C(N[C@@H](CC(N)=O)C(N6[C@@H](CCC6)C(N[C@H]5C(C)C)=O)=O)=O)=O)=O)=O)=O)[C@H](CCCNC(N)=N)N.FC(C(O)=O)(F)F–Neurological Disease–DMSO : ≥ 250 mg/mL–nAChR—-Membrane Transporter/Ion Channel;Neuronal Signaling–Peptides